1. Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents
   Federico Selvaggi et al, 2022, Cancers CrossRef
2. Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model
   Changcan Li et al, 2022, Frontiers in Immunology CrossRef
3. Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters
   Bo Zhai et al, 2008, World Journal of Gastroenterology CrossRef
4. Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy
   Marianeve Carotenuto et al, 2022, Exploration of Targeted Anti-tumor Therapy CrossRef
5. Cyclooxygenase-2–Derived Prostaglandin E2 Activates β-Catenin in Human Cholangiocarcinoma Cells: Evidence for Inhibition of These Signaling Pathways by ω3 Polyunsaturated Fatty Acids
   Kyu Lim et al, 2008, Cancer Research CrossRef
6. Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts
   Yasuni Nakanuma, 2009, World Journal of Hepatology CrossRef
7. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness
   Simone Brivio et al, 2017, World Journal of Hepatology CrossRef